Ads
related to: news sars-cov-2
Search results
Hologic, Inc. (NASDAQ:HOLX) Receives Average Recommendation of “Moderate Buy” from Brokerages
ETF DAILY NEWS· 4 days agoShares of Hologic, Inc. (NASDAQ:HOLX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the eleven brokerages that are currently covering the company, Marketbeat.com ...
FDA chides Cue Health for changing its home COVID test, tells consumers to throw them out
FierceBiotech· 15 hours agoThe agency also handed Cue a warning letter late last week, which said the modifications the company made to its tests’ hardware and firmware could result in the device failing earlier than ...
FDA Roundup: May 14, 2024
WPRI Providence· 13 hours agoOn Monday, the FDA's Office of Science and Engineering Laboratories launched an improved online Regulatory Science Tool (RST) Catalog to enhance search and browse capability as well as allow ...
Skirmish over paper drug info draws on
Politico· 15 hours ago“If testing was performed more than two weeks ago, and there is no reason to suspect current SARS-CoV-2 infection, it is not necessary ...
Deadly new Covid after-effect confirmed by scientists
MSN News· 2 days agoA deadly autoimmune disorder is on the rise in northern England, and scientists are now linking the...
Infinitopes' Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
WJTV Jackson· 6 days agoInfinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective ...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 4 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus
Zacks· 1 day agoQIAGEN (QGEN) receives FDA clearance for the QIAstat-Dx respiratory syndromic testing panel for fast and accurate results.
Gene therapy trials deliver double win
Nature· 6 days agoFinal results of two studies — whose preliminary data led to regulatory approval of the gene therapy exagamglogene autotemcel — describe highly effective...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 22 hours agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
